QIAGEN Announces Governance Changes and Proposal for Increased Returns at 2026 AGM
QIAGEN has announced plans for its 2026 Annual General Meeting, including the appointment of Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, continued renewal of the Supervisory Board, and proposals for increased shareholder returns. The meeting is scheduled for June 24, 2026, in Venlo, the Netherlands, and will also include the nomination of Robert McMahon as a new board member.
VENLO, Netherlands–(BUSINESS WIRE)—- $QGEN #QIAGEN–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced proposals for its 2026 Annual General Meeting, including plans to appoint co-founder and former Chief Executive Officer Dr. Metin Colpan as Honorary Chairman, the continued renewal of the Supervisory Board and increased returns to shareholders. The Annual General Meeting, to be held on June 24, 2026, in Venlo, the Netherlands, will include proposals to elect Robert McMahon as a new member of